Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery
- 21 August 1987
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 258 (7) , 931-935
- https://doi.org/10.1001/jama.258.7.931
Abstract
Research from JAMA — Treatment of Invasive Bladder Cancer by Cisplatin and Radiation in Patients Unsuited for SurgeryThis publication has 13 references indexed in Scilit:
- Combined radiation and chemotherapy for locally advanced transitional cell carcinoma of the urinary bladderCancer, 1985
- Preliminary Results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Transitional Cell Carcinoma of the UrotheliumJournal of Urology, 1985
- Cisplatin and Full Dose Irradiation for Patients with Invasive Bladder Carcinoma: A Preliminary Report of Tolerance and Local ResponseJournal of Urology, 1984
- Methotrexate in the Treatment of Metastatic and Recurrent Primary Transitional Cell CarcinomaJournal of Urology, 1984
- A comparison of short-course, low-dose and long-course, high-dose preoperative radiation for carcinoma of the bladderCancer, 1983
- A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A national bladder cancer collaborative group a studyCancer, 1983
- Adjuvant Chemotherapy with Doxorubicin (Adriamycin) and 5–Fluorouracil in T3, NX, MO Bladder Cancer Treated with RadiotherapyBritish Journal of Urology, 1983
- Treatment of T3 Bladder Cancer: Controlled Trial of Pre-operative Radiotherapy and Radical Cystectomy Versus Radical Radiotherapy: Second Report and Review (for the Clinical Trials Group, Institute of Urology)British Journal of Urology, 1982
- An evaluation of split-course irradiation for pelvic malignanciesInternational Journal of Radiation Oncology*Biology*Physics, 1980
- Bladder Carcinoma and a TNM System of ClassificationJournal of Urology, 1977